Shree Ganesh Remedies Limited (SGRL.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-127.1%

-₹168.00

vs ₹620.00 price

Levered DCF

-₹184.93

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	30.37×	40.57×	30.23×	18.01×	26.77×	41.51×	9.1×	9.41×
P/B	3.31×	6.45×	6.96×	3.44×	5.82×	8.1×	2.08×	1.74×
P/S	4.94×	8.62×	6.75×	3.4×	5.03×	8.25×	1.5×	1.66×
EV / EBITDA	14.63×	24.59×	19.39×	12.51×	16.49×	25.48×	5.81×	5.91×
Gross margin	41.7%	37.0%	53.6%	32.4%	37.5%	54.7%	38.9%	47.6%
Operating margin	22.5%	28.3%	45.5%	22.8%	21.5%	39.9%	15.8%	23.1%
Net margin	16.3%	21.2%	22.3%	18.9%	18.8%	19.9%	16.5%	17.7%
Current ratio	3.96×	4.79×	3.76×	2.71×	2.99×	3.73×	3.6×	3.8×
Debt / equity	0.19×	0.26×	0.3×	0.38×	0×	0×	0.05×	0.02×
Interest coverage	6.89×	14.58×	94.28×	177.82×	105.11×	296.08×	67.06×	49.86×
Dividend yield	0.0%	0.0%	0.1%	0.2%	0.4%	0.3%	1.4%	1.5%
Payout ratio	0.0%	0.0%	2.2%	3.5%	12.0%	13.8%	13.0%	14.4%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	10.9%	15.9%	23.0%	19.1%	21.8%	19.5%	22.9%	18.4%
Return on invested capital	9.3%	12.3%	26.4%	12.7%	18.4%	29.1%	15.5%	16.7%
Return on assets	8.6%	12.0%	16.4%	11.8%	17.4%	16.1%	18.4%	15.1%
Free cash flow yield	0.7%	0.8%	-0.1%	-11.3%	-0.5%	0.8%	4.4%	-9.1%
Earnings yield	3.3%	2.5%	3.3%	5.6%	3.7%	2.4%	11.0%	10.6%
Enterprise value	₹5.6B	₹9.6B	₹8.7B	₹3.3B	₹3.5B	₹4B	₹882.4M	₹584.7M
Net debt / EBITDA	0.46×	0.72×	0.46×	0.94×	-0.18×	-0.21×	0.04×	-0.02×
Cash conversion cycle (days)	192	162	164	143	149	223	126	153